Melinta Therapeutics (NASDAQ: MLNT)
Melinta Therapeutics Inc (NASDAQ: MLNT) is a biotechnology copany taking a novel approach to the treatment of various infections.
The company is in commercial stages, and in mid 2019, it announced that the FDA accepted a supplemental New Drug Application for BAXDELA, a treatment approved for skin infections. If approved, the label on BAXDELA will be expanded to include the treatment of community acquired bacteral pneumonia, entering a large
Visit the Melinta Therapeutics investor relations website here.